Inovio Pharmaceuticals, Inc. (INO) Financials
INO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 49.8 billion | 43.7 billion |
| Dec. 31, 2025 | 74.3 million | 50.2 million |
| Sept. 30, 2025 | 69.4 million | 77.1 million |
| June 30, 2025 | 68.2 million | 39.7 million |
INO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | -21.6 million | 698.7 million |
| Dec. 31, 2025 | -19.5 million | 764561 |
| Sept. 30, 2025 | -21.6 million | 757086 |
| June 30, 2025 | -20.8 million | 834792 |
INO Net Income
No data available :(
INO Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 37.7 billion | 5.8 billion | 5.8 million |
| Dec. 31, 2025 | 58.5 million | - | 9.4 million |
| Sept. 30, 2025 | 50.8 million | - | 7.3 million |
| June 30, 2025 | 47.5 million | - | 10.7 million |
INO Shares Outstanding
INO Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | 4 | 13.8 million | 7.9 billion | - |
| Dec. 31, 2025 | 127444 | 10.3 million | 7.2 million | - |
| Sept. 30, 2025 | 67951 | 13.3 million | 7.9 million | - |
| June 30, 2025 | 30930 | 14.2 million | 8.6 billion | - |
INO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | - | 745464 |
| Dec. 31, 2025 | -65343 | 754054 |
| Sept. 30, 2025 | - | 749656 |
| June 30, 2025 | - | 741670 |
INO Revenue by Segment
Graph available only for paid members. Upgrade to see it.
INO
Price: $1.12
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.58 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.8 million
Ebitda: -28.0 millionMarket Capitalization: 57.3 million